Profen and Isordil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Profen (ibuprofen) and Isordil (isosorbide dinitrate). Common drug interactions include dehydration among females and coronary artery occlusion among males.

The phase IV clinical study analyzes what interactions people have when they take Profen and Isordil. It is created by eHealthMe based on reports of 43 people who take the same drugs from the FDA, and is updated regularly.

What is Profen?

Profen has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 245,311 Profen users. Check the latest studies of Profen.

What is Isordil?

Isordil has active ingredients of isosorbide dinitrate. eHealthMe is studying from 3,022 Isordil users. Check the latest studies of Isordil.



On Jul, 14, 2026

43 people who take Profen and Isordil together, and have interactions are studied.

Profen and Isordil drug interactions.

What are the common drug interactions of Profen and Isordil, by gender? *:

female:

  1. Dehydration (dryness resulting from the removal of water)
  2. Emotional distress
  3. Gait disturbance
  4. Headache (pain in head)
  5. Hypertension (high blood pressure)
  6. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  7. Nausea (feeling of having an urge to vomit)
  8. Oedema peripheral (superficial swelling)
  9. Pulmonary embolism (blockage of the main artery of the lung)
  10. Pyrexia (fever)

male:

  1. Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
  2. Chronic kidney disease
  3. Vomiting
  4. Aortic valve incompetence
  5. Blood potassium decreased
  6. Bradycardia (abnormally slow heart action)
  7. Diarrhoea
  8. Dilatation ventricular
  9. Lactic acidosis (low ph in body tissues)
  10. Nausea (feeling of having an urge to vomit)

What are the common drug interactions of Profen and Isordil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  2. Pulmonary embolism (blockage of the main artery of the lung)
  3. Thrombophlebitis superficial (swelling (inflammation) of a superficial vein caused by a blood clot)

40-49:

  1. Hypoaesthesia (reduced sense of touch or sensation)
  2. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
  3. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  4. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  5. Nausea (feeling of having an urge to vomit)
  6. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  7. Productive cough
  8. Renal failure (kidney dysfunction)
  9. Renal failure acute (rapid kidney dysfunction)
  10. Vomiting

50-59:

  1. Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
  2. Pulmonary embolism (blockage of the main artery of the lung)
  3. Blood potassium decreased
  4. Chest pain
  5. Dilatation ventricular
  6. Hypotension (abnormally low blood pressure)
  7. Oxygen saturation decreased
  8. Chronic kidney disease
  9. Dyspnoea (difficult or laboured respiration)
  10. Hypokalaemia (low potassium)

60+:

  1. Injury
  2. Renal failure (kidney dysfunction)
  3. Foot deformity (functional disability of foot)
  4. Gait disturbance
  5. Gastrointestinal angiodysplasia haemorrhagic (a small vascular malformation of the gut with bleeding)
  6. Haemorrhagic anaemia (anaemia due to excessive bleeding)
  7. Head injury
  8. Hypotension (abnormally low blood pressure)
  9. Lactic acidosis (low ph in body tissues)
  10. Renal failure acute (rapid kidney dysfunction)

What are the existing conditions these people have? *

  1. Cardiac Disorder: 5 people, 11.63%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 9.30%
  3. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 9.30%
  4. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 3 people, 6.98%
  5. High Blood Cholesterol: 3 people, 6.98%

* Approximation only. Some reports may have incomplete information.

Do you take Profen and Isordil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Profen and Isordil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Profen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Isordil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Profen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Isordil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ibuprofen and isosorbide dinitrate (the active ingredients of Profen and Isordil, respectively), and Profen and Isordil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: